Journal profile · GENETICS & HEREDITY
Human Genomics
ISSN 1473-9542 · eISSN 1479-7364 · BioMed Central · ENGLAND · Founded 2003
Human Genomics: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.14; fully open access; APC about USD 3,290; median 91 days to acceptance (107 articles, last 24 months); 181 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Human Genomics is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, Genetic Associations and Epidemiology and Genomic variations and chromosomal abnormalities, together about 33.5% of its articles. Its main subfields are Genetics and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Human Genomics is a peer‑reviewed, open‑access journal dedicated to advancing understanding of how genomic variation shapes human biology, health, and disease. The journal publishes high‑quality original articles supporting biological discovery, clinical translation, precision medicine, and population and public health. The journal welcomes studies across the full spectrum of human genomics, including: Human genetics and genetic epidemiology Genome‑wide association studies (GWAS) and population genomics Whole‑genome and whole‑exome sequencing Functional, regulatory, and comparative genomics Epigenomics and transcriptomics Pharmacogenomics and toxicogenomics Statistical genetics and evolutionary genomics Clinical genomics, genomic medicine, and precision medicine Environmental genomics and gene–environment interactions Ethical, legal, and social implications (ELSI) of genomics Recognizing the data-driven nature of modern genomics, the journal strongly encourages submissions that apply advanced computational and quantitative approaches, including bioinformatics, machine learning, deep learning, artificial intelligence, integrative multi‑omics analysis, single‑cell and spatial genomics, and AI‑enabled variant interpretation or clinical decision support. Human Genomics aims to serve as a multidisciplinary platform at the intersection of genomics, medicine, environmental health, and data science, accelerating the translation of genomic discoveries into meaningful clinical and public health impact.
From the journal's Aims & Scope
Research area (LetPub): GENETICS & HEREDITY
Editor-in-chief Vasilis VasiliouPublisher website
Editorial board by country: 8 in mainland China (about 6%); most named United States 51, Mainland China 8, United Kingdom 7, Japan 6, United Arab Emirates 5 (135 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology14.6%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology13.1%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology5.9%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology5.6%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology5.4%
- Gene expression and cancer classificationBiochemistry, Genetics and Molecular Biology4.4%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.2%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.14LetPub ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.2Publisher website ·
- CiteScore 2026-06
- 6.4LetPub ·
- CiteScore (publisher)
- 1.6Publisher website ·
- SJR 2026-06
- 1.46LetPub ·
- SNIP 2026-06
- 1.34LetPub ·
- h-index
- 49LetPub ·
- h-index
- 94OpenAlex ·
- i10-index
- 645OpenAlex ·
- 2-year mean citedness
- 3.64OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 169LetPub ·
- Downloads per year (publisher) 2025
- 1,300,000Publisher website ·
Articles by year OpenAlex count · 1,343 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 154 | 154 | 53 |
| 2025 | 181 | 181 | 609 |
| 2024 | 141 | 141 | 1,073 |
| 2023 | 116 | 116 | 2,026 |
| 2022 | 73 | 73 | 1,733 |
| 2021 | 75 | 75 | 1,595 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 56 days – 154 days
- Acceptance to online
- median 18 days (107 articles)
- Submission to online
- median 120 days
- Sample
- 107 articles with submission and acceptance dates (368 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,290 / EUR 2,790 / GBP 2,490 | — | — | |
| LetPub | GBP 2,390 / USD 3,190 / EUR 2,690 | Yes | — | |
| Publisher website | GBP 2,590 / USD 3,390 / EUR 2,890 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted9
- brief reportResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- correspondenceResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- databaseResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- matters arisingResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- meeting reportResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- methodologyResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- perspectiveResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- researchResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
- reviewResearch Review Database Perspective Correspondence Meeting report Brief Report Matters Arising MethodologyLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data and materials sharing strongly encouraged or required; deposit in public repositories where appropriate. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Human Genomics articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Comm…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2003
- ISSN
- 1473-9542
- Electronic ISSN
- 1479-7364
- Society / sponsor
- Human Genome Organization
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Human Genomics
What CAS zone is Human Genomics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Human Genomics is in Zone 2 of Medicine, and in Zone 2 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Human Genomics?
The latest impact factor listed by LetPub is 4.14; CiteScore 6.4, h-index 94.
How long does peer review take at Human Genomics?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 56–154 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Human Genomics based?
Of the 135 board members whose country the journal's board page names, 8 (about 6%) are in mainland China; the countries named most often are United States (51), Mainland China (8) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Human Genomics?
According to LetPub and DOAJ records, Human Genomics is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Human Genomics open access, and what is the APC?
Human Genomics is a fully open-access journal. APC about USD 3,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .